EUROTOX returns in 2026—and this year’s congress will take place in Vienna, from 13–16 September 2026. The event continues to be one of the most important annual gatherings for toxicologists, researchers, and industry leaders across Europe.
As one of Europe’s leading toxicology experts, Scantox is excited to once again be part of this influential forum. We’ll be showcasing our full spectrum of toxicology and preclinical development services – expertise built over decades, supported by strong scientific depth, and powered by a flexible, partnership‑focused service model.
At Scantox, we cover a wide range of critical preclinical development stages, enabling our clients to move projects forward efficiently and confidently. Our services span:
- Lead optimization in both in vitro and in vivo efficacy models
- Formulation development
- Regulatory toxicology studies, including clinical pathology, bioanalysis, and histology
- Genetic Toxicology
By offering so many essential capabilities under one roof, we create a seamless and scientifically rigorous pathway from early discovery to clinical readiness, grounded in quality, transparency, and collaboration.
Visit us at EUROTOX 2026 to learn how Scantox can support and accelerate your development programs. We look forward to seeing you in Vienna!
